-+ 0.00%
-+ 0.00%
-+ 0.00%

OCULIS ANNOUNCES POSITIVE FDA PRE-IND FEEDBACK SUPPORTING PRIVOSEGTOR DEVELOPMENT STRATEGY FOR TREATMENT OF ACUTE MULTIPLE SCLEROSIS RELAPSES

路透·08/03/2026 08:00:00

登录查看新闻详情